Scienture Holdings, Inc. (SCNX): Total Assets
$84.18M
As of 2025-12-31
$87.73M
As of 2026-06-30
+183.1%
3-year compound annual growth
+53.8%
5-year compound annual growth
+45.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $84.18M | -19.7% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $104.85M | +736.6% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $12.53M | +237.8% | 2025-03-26, Balance as of period end |
| 2022-12-31 | $3.71M | -35.7% | 2024-04-22, Balance as of period end |
| 2021-12-31 | $5.77M | -41.1% | 2023-03-27, Balance as of period end |
| 2020-12-31 | $9.79M | +75.8% | 2022-03-28, Balance as of period end |
| 2019-12-31 | $5.57M | +150.1% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $2.23M | +260.8% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $617.5K | +83.2% | 2019-03-22, Balance as of period end |
| 2016-12-31 | $337.1K | -83.4% | 2018-03-02, Balance as of period end |
| 2015-12-31 | $2.03M | +65.9% | 2017-03-30, Balance as of period end |
| 2014-12-31 | $1.22M | +202.6% | 2016-03-28, Balance as of period end |
| 2013-12-31 | $403.9K | n/a | 2015-03-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $84.18M | -19.7% |
| Medicinova Inc (MNOV) | 2025-12-31 | $45.60M | -18.4% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $9.51M | +4.3% |
| America Great Health (AAGH) | 2025-06-30 | $301.8K | -6.7% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $45.92M | -39.9% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.67M | -25.3% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $5.33M | -60.5% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $697.5K | -30.7% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $131.44M | -35.1% |
Compare SCNX, MNOV, CANF, AAGH side by side · Screen every company in Pharmaceutical Preparations ↗